Moses Lake Pharmacy Recalls Estradiol Syringes Due to Sterility Concerns
Moses Lake Professional Pharmacy is recalling estradiol injectable syringes because the company cannot guarantee they are sterile.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility for an injectable drug, which poses a significant risk of serious injury or infection.
Plain-English summary
JD & SN Inc., doing business as Moses Lake Professional Pharmacy, is recalling two syringes of Estradiol Injectable Solution, 20 mg/mL, 5 mL. The recall was initiated because the pharmacy lacks assurance of the sterility of the product.
The affected product is a prescription-only compounded drug. The recall covers all sterile human compounded drugs within their expiration date. The distribution pattern for this recall is nationwide.
Consumers who have this product should stop using it and contact their healthcare provider or the pharmacy for further instructions.
The recalled product
- Product
- ESTRADIOL, Injectable Solution, 20 mg/mL, 5 mL syringe, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
- Category
- Drug — Injectable Solution
- Affected units
- 2
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- t03132015@5
- t05182015@21
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 101 recalled by JD & SN Inc., dba Moses Lake Professional Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 101 products in this recall →Related recalls
Same manufacturer · JD & SN Inc., dba Moses Lake Professional Pharmacy
See all →- SevereFDA Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Sodium Tetradecyl Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Six Trimix Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Compounded Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Compounded Progesterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- SeverePremier Pharmacy Labs Recalls Droperidol Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-07-03
- SevereApothecary Shoppe Recalls Estradiol and Progesterone Injectable Due to Sterility Concerns
FDA (Drugs) · 2013-10-09
- SevereRed Mountain Compounding Recalls S-Estradiol Cypionate Injections Due to Sterility Concerns
FDA (Drugs) · 2019-11-13
- HighEstradiol Cypionate Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2024-08-14
- SevereWells Pharmacy Recalls Mitomycin Solution Injectable Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereWestern Drug Recalls Testosterone Injections Due to Sterility Concerns
FDA (Drugs) · 2015-12-09